medigraphic.com
Academia Mexicana de Neurología, A.C.

2011, Number 1

<< Back Next >>

Rev Mex Neuroci 2011; 12 (1)

Anterior clinoid meningiomas

Díaz CA, Zottis GC, Rehder R, Borba LAB

Language: Spanish
References: 51
Page: 27-37
PDF size: 661.94 Kb.


ABSTRACT

Introduction: Meningiomas evolved around the ante-rior clinoid process consist of serious group amongsphenoid ridge due to their relationship to vascularand nervous structures. As clivus meningiomas, theyare associated to high mortality and morbidity rate.Objective: To evaluate the access, bone resectionextension, results, and complications associated toanterior clinoidal meningiomas surgery. Method: Reviewof 15 patients presenting anterior clinoidalmeningiomas submitted to surgical removal at Evangelico University Hospital of Curitiba during theperiod 2000 through 2010. Results: All patients weresubmitted to fronto-orbitozigomatic (FOZ) craniotomy;total resection was performed in 12 cases; partialremoval in 3 cases. Frequent complications are asfollows: III cranial nerve deficit (4 cases), motorimpairment (2 cases), cerebro-spinal fluid fistula (2cases), and facial pain (1 case). Visual recovery wasseen in 8 patients, while visual worsening in 2 patients.In 5 of cases, there were no visual alterations.Conclusion: Using skull base techniques, radicalresection of anterior clinoid meningiomas is possiblewhich includes bone and tumor exeresis, taking combined surgical approaches. Initial surgical processpresents the greatest opportunity to have totalresection, low morbidity, and mortality rates associatedto the low surgical risks.


REFERENCES

  1. 1.Cushing H, Eisenhardt L. Meningiomas. Their Classification, RegionalBehaviour, Life History, and Surgical End Results. Springfield II1: Char-les C Thomas; 1938, p. 298-319.

  2. 2.David M, Mahoudeau D. Les mrningiomes de la petite aile du sphrnoide(considerations anatomo-cliniques et thrrapeutiques). Gaz Med France1935; l I: 1-130.

  3. 3.Andrews BT, Wilson CB. Suprasellar meningiomas: the effect of tumorlocation on postoperative visual outcome. J Neurosurg 1988; 69: 523-8.

  4. 4.Brihaye J, Brihaye-van Geertruyden M. Management and surgical outcomeof suprasellar meningiomas. Acta Neurochir 1988; Suppl 42: 124-9.

  5. 5.Fohanno D, Bitar A. Sphenoidal ridge meningioma. Adv Tech StandNeurosurg 1986; 14: 137-74.

  6. 6.Grant FC. Intracranial meningiomas. Surgical results. Surg Gynecol Ohstet1947; 85: 419-31.

  7. 7.Bassiouni H, et al. Anterior clinoid meningiomas: functional outcomeafter microsurgical resection in a consecutive series of 106 patients.JNeurosurg; 1078-1090, 2009.

  8. 8.Bonnal J, Thibaut A, Brotchi J, et al. Invading meningiomas of thesphenoid ridge. J Neurosurg 1980; 53: 587-99.

  9. 9.Craig WM, Gogela LJ. Meningioma of the optic foramen as a cause ofslowly progressive blindness. J Neurosurg 1950; 7: 44-8.

  10. 10.Adegbite AB, Khan MI, Paine KWE, et al. The recurrence of intracranialmeningiomas after surgical treatment. J Neurosurg 1983; 58: 51-6.

  11. 11.Cophignon J, Lucena J, Clay C, et al. Limits to radical treatment ofspheno-orbital meningiomas. Acta Neurochir 1979; Suppl. 28: 375-80.

  12. 12.Mirimanoff RO, Dosoretz DE, Linggood RM, et al. Meningioma: analysisof recurrence and progression following neurosurgical resection. JNeurosurg 1985; 62: 18-24.

  13. 13.Simpson D. The recurrence of intracranial meningiomas after surgicaltreatment. J Neurol Neurosurg Psychiatry 1957; 20: 22-39.

  14. 14.A1-Mefty O. Surgery of the Cranial Base. Boston: Kluwer; 1988

  15. 15.AI-Mefty O, Smith RR. Surgery of tumors invading the cavernous sinus.Surg Neurol 1988; 30: 370-81.

  16. 16.Dolenc VV. Anatomy and Surgery of the Cavernous Sinus. Wien: Springer-Veflag; 1989.

  17. 17.Inoue T, Rhoton AL Jr, Theele D, Barry ME. Surgical approaches tothe cavernous sinus: a microsurgical study. Neurosurgery 1990; 26:903-32.

  18. 18.Natori Y, Rhoton AL Jr. Microsurgical anatomy of the superior orbitalfissure. Neurosurgery 1995; 36: 762-75.

  19. 19.Parkinson D. Optic strut: posterior root of sphenoid. Clin Anat 1989;2: 87-92.

  20. 20.Dolenc V. Microsurgical removal of large sphenoidal bonemeningiomas. Acta Neurochir (Wien) 1979; 28: 391-6.

  21. 21.Lee JH, Jeun SS, Evans J, Kosmorsky G. Surgical management of clinoidalmeningiomas. Neurosurgery 2001; 48: 1012-21.

  22. 22.Lee JH, Sade B, Park BJ. A surgical technique for the removal of clinoidalmeningiomas. Neurosurgery 2006; 59(1 Suppl. 1): ONS108-ONS114.

  23. 23.Al-Mefty O, Ayoubi S. Clinoidal meningiomas. Acta Neurochir Suppl(Wien) 1991; 53: 92-7.

  24. 24.Bonnal J, Thibaut A, Brotchi J, Born J. Invading meningiomas of thesphenoid ridge. J Neurosurg 1980; 53: 587-99.

  25. 25.CBTRUS (2008). Statistical report: Primary brain tumors in the UnitedStates, 2000 2004. Central Brain Tumor Registry of the United States.Hinsdale, IL: 2008.

  26. 26.Sloof J, Kernohan J, MacCarthy C. Primary Intramedullary Tumors of theSpinal Cord and Filum Terminale. Philadelphia, PA: WB Saunders;1964.

  27. 27.Baumgartner JE, Sorenson JM. Meningioma in the pediatric population.J Neurooncol 1996; 29: 223-8.

  28. 28.Rochat P, Johannesen HH, Gjerris F. Long-term follow-up of childrenwith meningiomas in Denmark: 1935 to 1984. J Neurosurg 2004; 100:179-82.

  29. 29.Al-Mefty O, Topsakal C, Pravdenkova S, et al. Radiationinducedmeningiomas: Clinical, pathological, cytokinetic, and cytogeniccharacteristics. J Neurosurg 2004; 100: 1002-13.

  30. 30.Ron E, Modan B, Boice JD, et al. Tumors of the brain and nervoussystem after radiotherapy in childhood. N Engl J Med 1988; 319(16):1033-9.

  31. 31.Christensen HC, Sch ¨uz J, Kosteljanetz M, et al. Cellular telephonesand risk for brain tumors: A population-based, incident case-controlstudy. Neurology 2005; 64(7): 1189-95.

  32. 32.Sch ¨uz J, B¨ohler E, Berg G, et al. Cellular phones, cordless phones,and the risks of glioma and meningioma (Interphone Study Group,Germany). Am J Epidemiol 2006; 163(6): 512-20.

  33. 33.Monteiro GT, Pereira RA, Kiofman RJ, et al. Head injury and braintumors in adults: A case-control study in Rio de Janeiro, Brazil. Eur JCancer 2006; 42(7): 917-21.

  34. 34.Preston-Martin S, Paganini-Hill A, Henderson BE, et al. Casecontrolstudy of intracranial meningiomas in women in Los Angeles County,California. J Natl Cancer Inst 1980; 65(1): 67-73.

  35. 35.Preston-Martin S, Pogoda JM, Schlehofer B, et al. An international case-control study of adult glioma and meningioma: The role of head trau-ma. Int J Epidemiol 1998; 27: 579-86.

  36. 36.Preston-Martin S, Yu MC, Henderson BE, et al. Risk factors formeningiomas in men in Los Angeles County. J Natl Cancer Inst 1983;70(5): 863-6.

  37. 37.Topp WC, Lane D, Pollack R. Transformation by SV40 and polyomavirus.In: Tooze J (ed.). DNA Tumor Viruses. New York, NY: Cold SpringHarbor Laboratory Press, Inc.; 1981, p. 200-301.

  38. 38.Wellenreuther R, Kraus JA, Lenartz D, et al. Analysis of theneurofibromatosis 2 gene reveals molecular variants of meningioma.Am J Pathol 1995; 146: 827-32.

  39. 39.Simon M, Bostrom JP, Hartmann C. Molecular genetics of meningiomas:From basic research to potential clinical applications. Neurosurgery2007; 60: 787-98.

  40. 40.Hansson CM, Buckley PG, Grigelioniene G, et al. Comprehensivegenetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. BMCGenomics 2007; 8: 16.

  41. 41.Perry A, Louis DN, Scheithauer BW, et al. Meningiomas. In: Kleihues P,Cavanee WK (eds.). Pathology and Genetics of Tumors of the NervousSystem: World Health Organization Classification of Tumors Lyon, France:IARC Press, 2007.

  42. 42.Lamszus K. Meningioma pathology, genetics, and biology. J NeuropatholExp Neurol 2004; 63(4): 275-86.

  43. 43.Drummond KJ, Zhu J, Black PM. Meningiomas: Updating basic science,management and outcome. Neurol 2004; 10(3): 113-30.

  44. 44Soyuer S, Chang EL, Selek U, et al. Radiotherapy after surgery for benigncerebral meningioma. Radiother Oncol 2004; 71: 85-90.

  45. 45..Turbin RE, Thompson CR, Kennerdell JS. A long-term visual outcomecomparison in patients with optic nerve sheath meningioma managedwith observation, surgery, radiotherapy, or surgery and radiotherapy.Ophthalmology 2002; 109: 890-900.

  46. 46.Goldsmith BJ, Wara WM, Wilson CB. Postoperative irradiation forsubtotally resected meningiomas. Aretrospective analysis of 140 patientstreated from1967 to 1990. J Neurosurg 1994; 80: 195-201.

  47. 47.Elia AE, Shih HA, Loeffler JS. Stereotactic radiation treatment for benignmeningiomas. Neurosurg Focus 2007; 23(4): E5.

  48. 48.Schrell UM, Rittig MG, Anders M, et al. Hydroxyurea for treatment ofunresectable and recurrent meningiomas. I. Inhibition of primary humanmeningioma cells in culture and in meningioma transplants by inductionof the apoptotic pathway. J Neurosurg 1997; 86: 845-52.

  49. 49.Ragel BT, Gillespie DL, Kushnir V, et al. Calcium channel antagonistsaugment hydroxyurea- and RU486-induced inhibition of meningiomagrowth in vivo and in vitro. Neurosurgery 2006; 59: 1109-21.

  50. 50.Zhang Z, Wang J, Muhr C, et al. Synergistic inhibitory effects of interferon-alpha and 5-fluorouracil in meningioma cells in vitro. Cancer Lett1996; 100: 99-105.

  51. 51.Kaba SE, DeMonte F, Bruner JM, et al. The treatment of recurrentunresectable and malignant meningiomas with interferon alpha-2B.Neurosurgery 1997; 40: 271-5.




2020     |     www.medigraphic.com